Literature DB >> 27337173

Tibiofemoral Contact Forces in the Anterior Cruciate Ligament-Reconstructed Knee.

David John Saxby1, Adam L Bryant, Luca Modenese, Pauline Gerus, Bryce A Killen, Jason Konrath, Karine Fortin, Tim V Wrigley, Kim L Bennell, Flavia M Cicuttini, Christopher Vertullo, Julian A Feller, Tim Whitehead, Price Gallie, David G Lloyd.   

Abstract

PURPOSE: To investigate differences in anterior cruciate ligament-reconstructed (ACLR) and healthy individuals in terms of the magnitude of the tibiofemoral contact forces, as well as the relative muscle and external load contributions to those contact forces, during walking, running, and sidestepping gait tasks.
METHODS: A computational EMG-driven neuromusculoskeletal model was used to estimate the muscle and tibiofemoral contact forces in those with single-bundle combined semitendinosus and gracilis tendon autograft ACLR (n = 104, 29.7 ± 6.5 yr, 78.1 ± 14.4 kg) and healthy controls (n = 60, 27.5 ± 5.4 yr, 67.8 ± 14.0 kg) during walking (1.4 ± 0.2 m·s), running (4.5 ± 0.5 m·s) and sidestepping (3.7 ± 0.6 m·s). Within the computational model, the semitendinosus of ACLR participants was adjusted to account for literature reported strength deficits and morphological changes subsequent to autograft harvesting.
RESULTS: ACLR had smaller maximum total and medial tibiofemoral contact forces (~80% of control values, scaled to bodyweight) during the different gait tasks. Compared with controls, ACLR were found to have a smaller maximum knee flexion moment, which explained the smaller tibiofemoral contact forces. Similarly, compared with controls, ACLR had both a smaller maximum knee flexion angle and knee flexion excursion during running and sidestepping, which may have concentrated the articular contact forces to smaller areas within the tibiofemoral joint. Mean relative muscle and external load contributions to the tibiofemoral contact forces were not significantly different between ACLR and controls.
CONCLUSIONS: ACLR had lower bodyweight-scaled tibiofemoral contact forces during walking, running, and sidestepping, likely due to lower knee flexion moments and straighter knee during the different gait tasks. The relative contributions of muscles and external loads to the contact forces were equivalent between groups.

Entities:  

Mesh:

Year:  2016        PMID: 27337173     DOI: 10.1249/MSS.0000000000001021

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  21 in total

1.  Greater magnitude tibiofemoral contact forces are associated with reduced prevalence of osteochondral pathologies 2-3 years following anterior cruciate ligament reconstruction.

Authors:  David John Saxby; Adam L Bryant; Ans Van Ginckel; Yuanyuan Wang; Xinyang Wang; Luca Modenese; Pauline Gerus; Jason M Konrath; Karine Fortin; Tim V Wrigley; Kim L Bennell; Flavia M Cicuttini; Christopher Vertullo; Julian A Feller; Tim Whitehead; Price Gallie; David G Lloyd
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-06-07       Impact factor: 4.342

2.  Poor knee function after ACL reconstruction is associated with attenuated landing force and knee flexion moment during running.

Authors:  Luke G Perraton; Michelle Hall; Ross A Clark; Kay M Crossley; Yong-Hao Pua; Tim S Whitehead; Hayden G Morris; Adam G Culvenor; Adam L Bryant
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-28       Impact factor: 4.342

3.  Training Load Monitoring in Team Sports: A Novel Framework Separating Physiological and Biomechanical Load-Adaptation Pathways.

Authors:  Jos Vanrenterghem; Niels Jensby Nedergaard; Mark A Robinson; Barry Drust
Journal:  Sports Med       Date:  2017-11       Impact factor: 11.136

4.  Gait mechanics and second ACL rupture: Implications for delaying return-to-sport.

Authors:  Jacob J Capin; Ashutosh Khandha; Ryan Zarzycki; Kurt Manal; Thomas S Buchanan; Lynn Snyder-Mackler
Journal:  J Orthop Res       Date:  2016-11-18       Impact factor: 3.494

5.  Gait Mechanics in Women of the ACL-SPORTS Randomized Control Trial: Interlimb Symmetry Improves Over Time Regardless of Treatment Group.

Authors:  Jacob J Capin; Ryan Zarzycki; Naoaki Ito; Ashutosh Khandha; Celeste Dix; Kurt Manal; Thomas S Buchanan; Lynn Snyder-Mackler
Journal:  J Orthop Res       Date:  2019-05-20       Impact factor: 3.494

6.  Report of the Primary Outcomes for Gait Mechanics in Men of the ACL-SPORTS Trial: Secondary Prevention With and Without Perturbation Training Does Not Restore Gait Symmetry in Men 1 or 2 Years After ACL Reconstruction.

Authors:  Jacob John Capin; Ryan Zarzycki; Amelia Arundale; Kathleen Cummer; Lynn Snyder-Mackler
Journal:  Clin Orthop Relat Res       Date:  2017-10       Impact factor: 4.176

7.  Biofeedback for Gait Retraining Based on Real-Time Estimation of Tibiofemoral Joint Contact Forces.

Authors:  Claudio Pizzolato; Monica Reggiani; David J Saxby; Elena Ceseracciu; Luca Modenese; David G Lloyd
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2017-04-18       Impact factor: 3.802

8.  Associations Between Slower Walking Speed and T1ρ Magnetic Resonance Imaging of Femoral Cartilage Following Anterior Cruciate Ligament Reconstruction.

Authors:  Steven Pfeiffer; Matthew S Harkey; Laura E Stanley; J Troy Blackburn; Darin A Padua; Jeffrey T Spang; Stephen W Marshall; Joanne M Jordan; Randy Schmitz; Daniel Nissman; Brian Pietrosimone
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-07-04       Impact factor: 4.794

9.  Sagittal plane walking biomechanics in individuals with knee osteoarthritis after quadriceps strengthening.

Authors:  H C Davis; B A Luc-Harkey; M K Seeley; J Troy Blackburn; B Pietrosimone
Journal:  Osteoarthritis Cartilage       Date:  2019-01-18       Impact factor: 6.576

10.  Running Biomechanics in Individuals with Anterior Cruciate Ligament Reconstruction: A Systematic Review.

Authors:  Benoit Pairot-de-Fontenay; Richard W Willy; Audrey R C Elias; Ryan L Mizner; Marc-Olivier Dubé; Jean-Sébastien Roy
Journal:  Sports Med       Date:  2019-09       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.